- Home
- FTAIM vs CRNX Comparison
FTAIM vs CRNX Comparison
Compare FTAIM & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTAIM
- CRNX
- Stock Information
- Founded
- FTAIM N/A
- CRNX 2008
- Country
- FTAIM United States
- CRNX United States
- Employees
- FTAIM 580
- CRNX N/A
- Industry
- FTAIM Misc Corporate Leasing Services
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- FTAIM Industrials
- CRNX Health Care
- Exchange
- FTAIM Nasdaq
- CRNX Nasdaq
- Market Cap
- FTAIM N/A
- CRNX 2.8B
- IPO Year
- FTAIM N/A
- CRNX 2018
- Fundamental
- Price
- FTAIM N/A
- CRNX $30.00
- Analyst Decision
- FTAIM
- CRNX Strong Buy
- Analyst Count
- FTAIM 0
- CRNX 10
- Target Price
- FTAIM N/A
- CRNX $75.00
- AVG Volume (30 Days)
- FTAIM N/A
- CRNX 646.9K
- Earning Date
- FTAIM N/A
- CRNX 08-07-2025
- Dividend Yield
- FTAIM N/A
- CRNX N/A
- EPS Growth
- FTAIM N/A
- CRNX N/A
- EPS
- FTAIM N/A
- CRNX N/A
- Revenue
- FTAIM N/A
- CRNX $760,000.00
- Revenue This Year
- FTAIM N/A
- CRNX $402.12
- Revenue Next Year
- FTAIM N/A
- CRNX $770.88
- P/E Ratio
- FTAIM N/A
- CRNX N/A
- Revenue Growth
- FTAIM N/A
- CRNX N/A
- 52 Week Low
- FTAIM N/A
- CRNX $24.10
- 52 Week High
- FTAIM N/A
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- FTAIM 53.95
- CRNX 44.17
- Support Level
- FTAIM $26.60
- CRNX $28.34
- Resistance Level
- FTAIM $26.93
- CRNX $30.01
- Average True Range (ATR)
- FTAIM 0.14
- CRNX 1.07
- MACD
- FTAIM -0.02
- CRNX -0.17
- Stochastic Oscillator
- FTAIM 45.45
- CRNX 36.41
About FTAIM FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares
FTAI Aviation Ltd is a aerospace company .It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.